Results from a tissue biopsy available when needed

Our Guardant360 TissueNext™ tissue biopsy test offers comprehensive genomic profiling to find actionable information when tissue testing is appropriate.

The latest addition to our portfolio of tests, the Guardant360 TissueNext™ test, can help improve the management of patients with advanced stage cancers.

Guardant360 TissueNext™ is an analytically validated comprehensive next-generation sequencing panel that includes clinically actionable biomarkers to enable informed treatment decisions for patients with advanced solid tumors.